Skip to content
Screener

uniQure QURE Royalty Financing Agreement Interest Expense

Royalty Financing Agreement Interest Expense at other companies

PVL
Palvella TherapeuticsPVLA
-$2.04M-67.8%
PVL
Palvella TherapeuticsPVLA
$2.04M+67.8%
PTH
Pelthos TherapeuticsPTHS
$5M+300%
PTH
Pelthos TherapeuticsPTHS
$55K
PTH
Pelthos TherapeuticsPTHS
$588K
LFT
Lument Finance TrustLFT
$567.14K

Segments

By segment

See full
Single Reportable$12.96M-5.9%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept qure:RoyaltyFinancingAgreementInterestExpense.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Depreciation and amortization7,8638,157
Amortization of discount on investment securities(7,907)(4,163)
Share-based compensation expense10,1069,494
Royalty financing agreement interest expense, net of interest paid17,38420,626
Deferred tax expense2,329921
Changes in fair value of contingent consideration(82)3,470
Changes in fair value of liability related to pre-funded warrants12,201
Unrealized foreign exchange losses / (gains), net8,329(25,163)

Item 1.Financial Statements

FAQ

What is uniQure's royalty financing agreement interest expense?
uniQure (QURE) reported royalty financing agreement interest expense of $10.21M in Q2 2026.
How has uniQure's royalty financing agreement interest expense changed year-over-year?
uniQure's royalty financing agreement interest expense decreased by 16.8% year-over-year, from $12.27M to $10.21M.
What does royalty financing agreement interest expense mean?
This captures the interest expense associated with specialized financing arrangements where future royalty streams are pledged as collateral. It reflects the cost of capital for non-dilutive funding mechanisms common in biotechnology. Monitoring this helps assess the impact of royalty-based debt on long-term profitability.

Ask your AI about uniQure's royalty financing agreement interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude